the imwg frailty score explained
Published 1 year ago • 255 plays • Length 3:06Download video MP4
Download video MP3
Similar videos
-
2:25
novel ai model for personalized risk stratification & treatment in newly diagnosed multiple myeloma
-
3:32
a polygenic risk score to determine a patient's predisposition to cll
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
14:36
hematology in 10 min: hypercoagulobility state and application
-
1:06
clinical hematology: moving forward
-
1:34
the future role of ai models in hematology and the need for high-quality data sets
-
1:34
are thrombotic risk and progression in et predictable?
-
7:25
ai in hematology: advances, challenges, and future applications
-
37:35
oxygen hemoglobin dissociation curve - comprehensive and clear explanation!
-
19:58
how to write an amazing personal statement for any university application.
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
1:26
how is frailty defined? what does it mean to be fit, intermediate fit, and frail?
-
1:35
the future directions of cll research: mechanisms of pathogenesis and novel biomarkers
-
1:25
are frailty scores being used in clinical trials? how?
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
3:13
the ultragenyx phase 2 and 3 orbit study
-
2:52
frailty: every step you take matters!
-
2:16
blood, official journal of the american society of hematology
-
2:22
clinical & experimental immunology moving forward: the journal of translational immunology
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma